🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

3 recruiting trials

for Proliferative Diabetic Retinopathy (PDR)

Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR NCT06790784Phase 334 sites📍 Huntington Beach📍 Loma Linda📍 San Francisco Jaeb Center for Health Research · Tests: Vitrectomy, Endolaser, Faricimab, Panretinal Photocoagulation (PRP) The Preliminary Safety and Efficacy of RRG001 After Vitrectomy in Subjects With Proliferative Diabetic Retinopathy (PDR) NCT06412224EARLY Phase 11 site📍 Tianjin Li Xiaorong · Tests: RRG001 Early Vitrectomy vs PRP in Early Proliferative Diabetic Retinopathy NCT07586787NA6 sites📍 Beijing📍 Xiamen📍 Zhengzhou Xiamen Ophthalmology Center Affiliated to Xiamen University · Tests: Microincision Vitrectomy Surgery, Panretinal Photocoagulation
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy